Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array solutions to fuel genomic discoveries
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
IMDEA Alimentación healthtech, Research Services | Other 15 Apr 2024 | | ||
EVOSCIENCES SAS fintech, Financial Services, deeptech | Other 28 May 2024 | | ||
Com'Publics consulting, Public Relations and Communications Services | Other 5 Mar 2024 | | ||
NunaBio Limited biotech, manufacturing, deeptech, Research Services | Other 7 Mar 2024 | | ||
Samplix biotech, deeptech, Biotechnology Research | Other 29 Feb 2024 | | ||
Les Chirurgiens-Dentistes de France entertainment, Hospitals and Health Care | Other 29 Feb 2024 | | ||
Fresh Brewed Tech Broadcast Media Production and Distribution | Other 31 Mar 2024 | | ||
cofinitive constructiontech, consulting, martech, Public Relations and Communications Services | Other 23 Feb 2024 | | ||
Fortune Book and Periodical Publishing | Other 27 Feb 2024 | | ||
Forbes Book and Periodical Publishing | Other 27 Feb 2024 | |